-Frontline Farmers protest against the Central clearance for coal bed methane exploration in Mannargudi, Tamil Nadu, as they fear it will devastate agriculture in Tiruvarur and Thanjavur districts.  THE woes of the delta farmers of Tamil Nadu are far from over. While the Cauvery tangle continues unresolved, they fear the proposed multi-crore project for commercial exploration and exploitation of coal bed methane (CBM) in the Mannargudi block of Tiruvarur district will prove...

-The Hindu Though more people in India are in the textile sector, than in any other of the economy, bar agriculture, hostile and indifferent government policies are giving it short shrift Handloom weavers from all over the country are on a 72-hour hunger strike at Jantar Mantar in New Delhi from today in protest against the government’s textile policy. The protest is led by Rastra Cheneta Jana Samakhya, the State Handloom Weavers’...

-Tehelka Here are the gaping holes in the argument for FDI in retail. No smooth talk can pave over it TOUTED AS a cure-all for India’s economic ills, Foreign Direct Investment (FDI) in multi-brand retail is at best an anodyne, and at worst, toxic. It is an attempt to lift markets by fabricating sentiment; signalling an economic turnaround without any concrete steps being taken to trim the fiscal deficit or boost manufacturing. All...

-One World South Asia South Asia’s households fall into poverty as the result of higher food prices as food prices increase. According to the latest Food Price Watch, global food prices increased 10% between June and July 2012 with staples such as wheat increasing 25% in the period. The crisis continued affecting food and nutrition security throughout South Asia. Bad weather, trade curbs, oil prices and bio-fuel diversions have all led to...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...